Literature DB >> 24426219

Serum Paraoxonase (PON1) Activity in North-West Indian Punjabi's with Acute Myocardial Infarction.

V Nagarjuna Maturu1, Nidhi Gupta2, Gagandip Singh3, Kirandip Gill2, Yash Paul Sharma3, Surjit Singh1.   

Abstract

Human serum paraoxonase-1 (PON1), an enzyme on HDL prevents oxidation of LDL thereby preventing the development of atherosclerosis. Studies done so far have lead to conflicting results. As studies are lacking in North-West Indian Punjabi's, a distinct ethnic group with high incidence of coronary artery disease, we determined PONase activity in this population. It has been postulated that sudden lowering of serum PONase may lead to precipitation of acute myocardial infarction. We determined serum PONase activity and lipids in 100 patients each of AMI (within 24 h of onset), stable CAD and 100 age and sex matched healthy controls. These were again determined after 6 weeks in AMI patients. The mean serum PONase activity was lowest in AMI patients (23.26 U/ml) followed by stable CAD patients (102.0 U/ml) where as in controls was highest (179.8 U/ml). In patients with AMI, activity was significantly higher at 6 weeks as compared to that after acute event (49.39 %; p < 0.05). Sudden lowering of serum PONase activity in a population which already has lower activity may be one of the risk factors for development of AMI.

Entities:  

Keywords:  Acute myocardial infarction; Atherosclerosis; Coronary artery disease; Paraoxonase-1

Year:  2012        PMID: 24426219      PMCID: PMC3689331          DOI: 10.1007/s12291-012-0260-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  32 in total

Review 1.  Paraoxonase and atherosclerosis.

Authors:  P N Durrington; B Mackness; M I Mackness
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

2.  Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status.

Authors:  Amar Nagila; Thinnakorn Permpongpaiboon; Soontharee Tantrarongroj; Pornwalee Porapakkham; Kultira Chinwattana; Sara Deakin; Sureerut Porntadavity
Journal:  Pharmacol Rep       Date:  2009 Sep-Oct       Impact factor: 3.024

3.  Serum arylesterase activity is negatively correlated with inflammatory markers in patients with acute coronary syndromes.

Authors:  Tunay Senturk; Emre Sarandol; Sumeyye Gullulu; Selda Erdinc; Osman Ozdabakoglu; Bulent Ozdemir; Ibrahim Baran; Sinan Arslan; Ali Aydinlar
Journal:  Saudi Med J       Date:  2009-03       Impact factor: 1.484

4.  Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.

Authors:  Thomas M van Himbergen; Yvonne T van der Schouw; Hieronymus A M Voorbij; Lambertus J H van Tits; Anton F H Stalenhoef; Petra H M Peeters; Mark Roest
Journal:  Atherosclerosis       Date:  2007-12-27       Impact factor: 5.162

5.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.

Authors:  D M Shih; L Gu; Y R Xia; M Navab; W F Li; S Hama; L W Castellani; C E Furlong; L G Costa; A M Fogelman; A J Lusis
Journal:  Nature       Date:  1998-07-16       Impact factor: 49.962

6.  Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients--a case controlled study from India.

Authors:  Arun Kumar; Suryakant Nagtilak; Ramiah Sivakanesan; Susil Gunasekera
Journal:  Southeast Asian J Trop Med Public Health       Date:  2009-05       Impact factor: 0.267

7.  Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.

Authors:  J A Troughton; J V Woodside; J W G Yarnell; D Arveiler; P Amouyel; J Ferrières; P Ducimetière; C C Patterson; G Luc
Journal:  Atherosclerosis       Date:  2007-09-27       Impact factor: 5.162

8.  Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.

Authors:  Larry Baum; Ho Keung Ng; Kam Sang Woo; Brian Tomlinson; Timothy Hudson Rainer; Xiangyan Chen; Wing Sze Cheung; Daniel Kam Yin Chan; G Neil Thomas; Cindy See Wai Tong; Ka Sing Wong
Journal:  Clin Biochem       Date:  2006-02-09       Impact factor: 3.281

9.  Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis.

Authors:  Nidhi Gupta; Surjit Singh; V Nagarjuna Maturu; Yash Paul Sharma; Kiran Dip Gill
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

10.  Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.

Authors:  Rakesh S Birjmohun; Menno Vergeer; Erik S G Stroes; Manjinder S Sandhu; Sally L Ricketts; Michael W Tanck; Nicholas J Wareham; J Wouter Jukema; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more
  3 in total

1.  Low serum paraoxonase1 activity levels predict coronary artery disease severity.

Authors:  Ting Sun; Jingchao Hu; Zhaofang Yin; Zuojun Xu; Liang Zhang; Li Fan; Yang Zhuo; Changqian Wang
Journal:  Oncotarget       Date:  2017-03-21

2.  The association between paraoxonase 1 activity and the susceptibilities of diabetes mellitus, diabetic macroangiopathy and diabetic microangiopathy.

Authors:  Diling Wu; Chenfang Wu; Yanjun Zhong
Journal:  J Cell Mol Med       Date:  2018-07-07       Impact factor: 5.310

Review 3.  Effect of Carotenoids on Paraoxonase-1 Activity and Gene Expression.

Authors:  Aneta Otocka-Kmiecik
Journal:  Nutrients       Date:  2022-07-11       Impact factor: 6.706

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.